Home › Funds › Michelson Medical Research Foundation, Inc. › IBB

Michelson Medical Research Foundation, Inc. position in IBB

ISHARES TR

Michelson Medical Research Foundation, Inc. reported holding 35,095 shares of IBB (ISHARES TR) in its Q3 2026 13F filing — a position valued at US$7.4M, representing 6.57% of its reported portfolio and ranking #6 among its reported holdings. Michelson Medical Research Foundation, Inc. has disclosed IBB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)35.09K sh
Reported value held$7.39M
Portfolio Weight6.57%
First reportedQ3 2023
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Michelson Medical Research Foundation, Inc.'s IBB position evolved

Michelson Medical Research Foundation, Inc. first disclosed a stake in IBB in Q3 2023 at 43,395 shares (US$5.3M). The position peaked in Q3 2026 at 35,095 shares, worth US$7.4M. Across 13 filings, Michelson Medical Research Foundation, Inc. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 35,095 shares valued at US$7.4M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 43.40K $5.31M New
Q4 2023 43.40K $5.90M Hold
Q1 2024 43.40K $5.95M Hold
Q2 2024 43.40K $5.96M Hold
Q3 2024 43.40K $6.32M Hold
Q4 2024 43.40K $5.74M Hold
Q1 2025 43.40K $5.55M Hold
Q2 2025 35.09K $4.44M Reduce
Q3 2025 35.09K $5.07M Hold
Q4 2025 35.09K $5.92M Hold
Q1 2026 35.09K $5.93M Hold
Q2 2026 35.09K $6.67M Hold
Q3 2026 35.09K $7.39M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IBB and 13F data

IBB (ISHARES TR) is a company whose sector is not yet classified in our data. 26 other funds we track also report a position in IBB — the largest reported positions include Citigroup Inc (US$963.2M), BNP PARIBAS FINANCIAL MARKETS (US$517.8M), COMMERCE BANK (US$190.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IBB

All IBB fund holders →

FAQ

How long has Michelson Medical Research Foundation, Inc. held IBB?

Michelson Medical Research Foundation, Inc. has disclosed IBB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Michelson Medical Research Foundation, Inc.'s current position in IBB?

As of Q3 2026, Michelson Medical Research Foundation, Inc. holds 35.09K shares of IBB (ISHARES TR), valued at $7.39M, representing 6.57% of its reported portfolio and ranking #6.

Has Michelson Medical Research Foundation, Inc. been buying or selling IBB?

In the latest 13F filing (Q3 2026), Michelson Medical Research Foundation, Inc. held unchanged its position in IBB. The position peaked in Q3 2026 at 35.09K shares.

Which other funds hold IBB?

Other major institutional holders of IBB include Citigroup Inc, BNP PARIBAS FINANCIAL MARKETS, COMMERCE BANK, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.